WATSON 3359 WATSON 3359 Pill - pink capsule/oblong, 14mm
Pill with imprint WATSON 3359 WATSON 3359 is Pink, Capsule/Oblong and has been identified as Tacrolimus 5 mg. It is supplied by Watson Laboratories, Inc.
Tacrolimus is used in the treatment of Organ Transplant, Rejection Prophylaxis; Organ Transplant, Rejection Reversal and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 3359 WATSON 3359
Tacrolimus
- Imprint
- WATSON 3359 WATSON 3359
- Strength
- 5 mg
- Color
- Pink
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcineurin inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-3359 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
croscarmellose sodium,
hypromelloses,
magnesium stearate,
gelatin,
titanium dioxide,
FD&C Blue No. 1,
FD&C Red No. 3,
FD&C Red No. 40
Note: Inactive ingredients may vary.
More about tacrolimus
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (47)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: calcineurin inhibitors
- Breastfeeding
- En español
Patient resources
- Tacrolimus oral and injection drug information
- Tacrolimus (Intravenous) (Advanced Reading)
- Tacrolimus (Oral) (Advanced Reading)
- Tacrolimus Capsules
- Tacrolimus Extended-Release Tablets
Other brands
Prograf, Envarsus XR, Astagraf XL, Hecoria
Professional resources
Other brands
Prograf, Envarsus XR, Astagraf XL
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
